Mark Parta

Frederick National Laboratory for Cancer Research — United States

Immunology and Microbiology · Life Sciences

21h-index1.4kcitations64works6.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immunodeficiency and Autoimmune Disorders(15), Hematopoietic Stem Cell Transplantation(14), Antifungal resistance and susceptibility(10), Neutrophil, Myeloperoxidase and Oxidative Mechanisms(9), Antimicrobial Resistance in Staphylococcus(7)

Publications64 total

Intermediate-dose posttransplantation cyclophosphamide for myeloablative HLA-haploidentical bone marrow transplantation
Blood Advances·2025· 18 citedOpen Access
Pharmacokinetic (PK) Exposure of 4-Hydroxycyclophosphamide Associates with Clinical Benefits of Reduced-Dose Post-Transplantation Cyclophosphamide: Results of a Completed Phase I/II Trial to De-Escalate Post-Transplantation Cyclophosphamide for HLA-Haploidentical Myeloablative Bone Marrow Transplantation
Blood·2024
Outcomes in hematopoetic cell transplantation in the setting of mold infections in patients with chronic granulomatous disease
Bone Marrow Transplantation·2024· 5 citedOpen Access
Human papillomavirus disease in GATA2 deficiency: a genetic predisposition to HPV-associated female anogenital malignancy
Frontiers in Immunology·2024· 4 citedOpen Access
Allogeneic hematopoietic cell transplantation is effective for p47phox chronic granulomatous disease: A  Primary Immune Deficiency Treatment Consortium study
Journal of Allergy and Clinical Immunology·2024· 7 citedOpen Access
S10.5d Disseminated pulmonary infection due to <i>Mortierella wolfii</i> in a 6-year-old patient with X-linked CGD receiving MUD-HSCT
Medical Mycology·2022· 1 citedOpen Access
Correction to: Hematopoietic Stem Cell Transplantation in late-onset X-linked Chronic Granulomatous Disease in a female carrier
Journal of Clinical Immunology·2022Open Access
Hematopoietic Stem Cell Transplantation in Late-onset X-linked Chronic Granulomatous Disease in a Female Carrier
Journal of Clinical Immunology·2022· 4 citedOpen Access
Prospective Clinical Trial of Mycophenolate Mofetil (MMF) De-Escalation in Allogeneic Hematopoietic Cell Transplantation (HCT) for Primary Immunodeficiency (PID): MMF Is Dispensable in Reduced-Intensity Conditioning, Posttransplantation Cyclophosphamide(PTCy)-Based HCT
Transplantation and Cellular Therapy·2022· 1 cited
Febrile neutropenia management and outcomes in hematopoietic cell transplantation for chronic granulomatous disease
Transplant Infectious Disease·2022· 1 citedOpen Access
Donor source and post‐transplantation cyclophosphamide influence outcome in allogeneic stem cell transplantation for GATA2 deficiency
British Journal of Haematology·2021· 30 citedOpen Access
Pulmonary Manifestations of GATA2 Deficiency
CHEST Journal·2021· 44 citedOpen Access
Late-onset X-linked Chronic Granulomatous Disease in a Female Carrier: Therapeutic Role of Interferon-γ and Hematopoietic Stem Cell Transplantation
Research Square (Research Square)·2021Open Access
Hematopoietic Cell Transplantation and Outcomes Related to Human Papillomavirus Disease in GATA2 Deficiency
Transplantation and Cellular Therapy·2021· 14 citedOpen Access
Failure to Prevent Severe Graft-Versus-Host Disease in Haploidentical Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide in Chronic Granulomatous Disease
Journal of Clinical Immunology·2020· 24 citedOpen Access
BK Virus-Associated Hemorrhagic Cystitis in Allogeneic Hematopoietic Cell Transplantation (HCT) Recipients with Primary Immunodeficiency
Biology of Blood and Marrow Transplantation·2020Open Access
1689. Active, Invasive Fungal Infection, and Hematopoietic Cell Transplantation (HCT) in Chronic Granulomatous Disease (CGD): Presentation, Procedure, and Outcomes
Open Forum Infectious Diseases·2019· 2 citedOpen Access
Dynamic Emergence of Mismatch Repair Deficiency Facilitates Rapid Evolution of Ceftazidime-Avibactam Resistance in Pseudomonas aeruginosa Acute Infection
mBio·2019· 39 citedOpen Access
Prospective Study of a Novel, Radiation-Free, Reduced-Intensity Bone Marrow Transplantation Platform for Primary Immunodeficiency Diseases
Biology of Blood and Marrow Transplantation·2019· 43 citedOpen Access
Case Report: Ocular toxoplasmosis in a WHIM syndrome immunodeficiency patient
F1000Research·2019· 3 citedOpen Access
page 1 of 4Next →

Frequent Co-authors

Steven M. Holland(26), Dennis D. Hickstein(17), Christa S. Zerbe(15), Jennifer Cuellar‐Rodríguez(13), Alexandra F. Freeman(13), Juan Gea‐Banacloche(12), Nirali N. Shah(11), Harry L. Malech(11), Elizabeth M. Kang(10), Katherine R. Calvo(7), Corin Kelly(7), Luigi D. Notarangelo(7), Thomas E. Hughes(6), Amy P. Hsu(6), Kristen Cole(4), Daniel M. Musher(4), Helen C. Su(4), Heidi H. Kong(4), Dimana Dimitrova(4), Jennifer A. Kanakry(4)